| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| Cost of Revenue | $0 | — | — |
| Gross Profit | $0 | — | — |
| R&D Expense | $465K | -7.2% | -20.0% |
| SG&A Expense | $777K | +6.2% | +55.8% |
| Operating Income | -$1.3M | -0.8% | -14.7% |
| Pre-tax Income | -$1.2M | -0.2% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Inventory | $994 | +0.0% | -70.7% |
| Current Assets | $5.4M | -18.4% | -14.5% |
| Total Assets | $5.9M | -17.6% | -15.0% |
| Current Liabilities | $261K | -5.9% | -21.0% |
| Total Liabilities | $261K | -5.9% | -21.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.9M | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $3.4M | — | — |
| -18.8% |
| Income Tax | $0 | — | — |
| Net Income | -$1.2M | -0.2% | -18.8% |
| EPS (Diluted) | -$0.48 | +0.0% | +36.0% |
| $5.6M |
| -18.1% |
| -14.7% |